Rapid PEP to PrEP Increased PrEP Uptake — But the Cost of Long-Acting Cabotegravir Remains Concerning
Illuminating the Benefits of COVID-19 Vaccination in the U.S.
Even Mild COVID-19 Can Lead to Substantial Brain Changes
Immunization with an mRNA COVID-19 Vaccine Isn't Associated with Appendicitis
SARS-CoV-2 Induces Brain Inflammation in Monkeys
Tixagevimab/Cilgavimab Prevents Symptomatic COVID-19
Group A Strep Outbreaks and Home Healthcare
More Evidence That Second-Line Dolutegravir Is Not Inferior to Ritonavir-Boosted Darunavir
Distinguishing COVID-19 Caused by Omicron vs. Delta
COVID-19 Vaccines and Risk for Guillain-Barré Syndrome

Pages